These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1975757)

  • 1. Reduction in antipsychotic drug dosage in mentally handicapped patients. A hospital study.
    Wressell SE; Tyrer SP; Berney TP
    Br J Psychiatry; 1990 Jul; 157():101-6. PubMed ID: 1975757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior disorders in persons with mental retardation receiving antipsychotic medication.
    Ono Y
    Res Dev Disabil; 1998; 19(2):123-30. PubMed ID: 9547524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.
    Youssef HA; Waddington JL
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):863-5. PubMed ID: 2900294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptics and epilepsy in mentally handicapped patients.
    James DH
    J Ment Defic Res; 1986 Jun; 30 ( Pt 2)():185-9. PubMed ID: 2874230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
    Rao JM; Cowie VA; Mathew B
    J Ment Defic Res; 1989 Feb; 33 ( Pt 1)():81-6. PubMed ID: 2564436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour.
    Kiernan C; Reeves D; Alborz A
    J Intellect Disabil Res; 1995 Aug; 39 ( Pt 4)():263-74. PubMed ID: 7579984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of antipsychotics' prescription in Portuguese acute psychiatric wards: A cross-sectional study.
    Campos Mendes J; Azeredo-Lopes S; Cardoso G
    Psychiatry Res; 2016 Dec; 246():142-148. PubMed ID: 27693867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults.
    Janowsky DS; Barnhill LJ; Shetty M; Davis JM
    J Clin Psychopharmacol; 2005 Feb; 25(1):19-25. PubMed ID: 15643096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients.
    Carter G
    Br J Psychiatry; 1983 Feb; 142():166-8. PubMed ID: 6132644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses.
    Leblanc G; Cormier H; Gagné MA; Vaillancourt S
    Can J Psychiatry; 1994 May; 39(4):223-9. PubMed ID: 7913872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the long term efficacy of antipsychotic drugs in controlling the behavior of institutionalized retardates.
    Zimmermann RL; Heistad GT
    J Am Acad Child Psychiatry; 1982 Mar; 21(2):136-43. PubMed ID: 6121828
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychiatric disturbance in mentally handicapped patients. A prospective study of current clinical usage of depot fluphenazine in hospitals for the mentally handicapped.
    Craft MJ; Schiff AA
    Br J Psychiatry; 1980 Sep; 137():250-5. PubMed ID: 7437659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of inpatient depot antipsychotic prescribing.
    Pabis DJ; Dorson PG; Crismon ML
    Ann Pharmacother; 1996 Dec; 30(12):1381-6. PubMed ID: 8968447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drug doses in a schizophrenia inpatient unit.
    Galletly CA
    Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
    Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
    J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing requirements of the elderly mentally handicapped: future demands on primary health care teams.
    Walters RM
    J R Coll Gen Pract; 1988 Jul; 38(312):317-9. PubMed ID: 2978420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.